Jakarta, Oct. 31 -- The Investment Management Agency of Daya Anagata Nusantara (Danantara Indonesia) has signed a Memorandum of Understanding (MoU) with South Korean healthcare company SK Plasma Co. Ltd and its subsidiary, PT SK Plasma Core Indonesia.

The partnership marks a strategic step to strengthen Indonesia's health resilience by reducing dependence on imports and enhancing self-sufficiency in healthcare services.

Danantara Indonesia's Chief Investment Officer, Pandu Sjahrir, said that one of Danantara's key investment focuses is reinforcing national resilience in critical sectors, including healthcare.

He noted that the collaboration between SK Plasma's technical expertise and Danantara's investment aims to improve patient care ...